Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Media · CIK 0001666071
$1.78
-4.81% · live
Updated
$11.0M market value
From Cardlytics, Inc.'s FY2025 10-K, filed Mar 4, 2026 · read the filing
Cardlytics makes and sells software and computing services. It took in $212.3M last year, which makes it a smaller company. It spends more than it earns — losing about 49 cents on every dollar of sales.
The filing does not provide enough evidence for a clear financial conclusion.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
A published bankruptcy-risk model places it in its distress range. This is a statistical reading, not a forecast.
Altman Z-Score -17.09
Recent open-market selling by 4 insiders, not under a pre-arranged plan.
$180.9K sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Significant financial weakness across most measures.
From Cardlytics, Inc.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Operating income
-$195.5M → -$101.8M
Profit
-$189.3M → -$103.5M
Operating margin
-76.5% → -48.0%
Profit margin
-74.1% → -48.7%
Measured against FY2024, from the 10-K filed Mar 4, 2026
Improved: $93.7M narrower
-$195.5M to -$101.8MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: $85.8M narrower
-$189.3M to -$103.5MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote live), and what was published around it
CDLX fell 4.81% on the latest quote. The average Technology company tracked here moved −1.27%, and the S&P 500 −0.14%. That is 3.5 points below its sector and 4.7 points below the market.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 6% a year for the next 10 years. Over the last 6 years it grew by about 19% a year.
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $103.5M last year, losing about 49 cents on every dollar of sales.
No. Sales shrank 16.9% last year.
Yes. Clearing its debt would take roughly 17.6 years of cash flow. For every $1 it owes, it owns $0.98 in assets. A bankruptcy-risk model also places it in its distress range.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it lost $103.5M and generated $9.3M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Mar 4, 2026Filing for FY2025 | FY202410-K · Mar 12, 2025Filing for FY2024 | FY202310-K · Mar 12, 2025Filing for FY2023 | FY202210-K · Mar 1, 2023Filing for FY2022 | FY202110-K · Mar 1, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $212.3M | $255.6M | $285.4M | $277.2M | $258.8M | −16.9% |
| Selling, general and administrative | $47.3M | $56.5M | $58.8M | $81.4M | $66.2M | −16.3% |
| Operating income | -$101.8M | -$195.5M | -$135.7M | -$457.8M | -$122.6M | +47.9% |
| Operating marginOperating income ÷ revenueWhat is this? | -48.0% | -76.5% | -47.5% | -165.2% | -47.4% | +28.5 pts |
| Interest expense | -$10.6M | $8.9M | $3.8M | $3.8M | $12.7M | n/m |
| Income before tax | -$103.5M | -$189.3M | -$134.7M | -$466.7M | -$136.4M | +45.3% |
| Net income | -$103.5M | -$189.3M | -$134.7M | -$465.3M | -$128.6M | +45.3% |
| Net marginNet income ÷ revenueWhat is this? | -48.7% | -74.1% | -47.2% | -167.9% | -49.7% | +25.3 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-1.90 | $-3.69 | $-3.39 | $-13.79 | $-4.61 | +48.6% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Exercised stock options — 18,750 shares
Holds 144,139 shares after this filing.
Exercised stock options — 12,500 shares
Holds 156,639 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Signed a material agreement
Read the filingQuarterly report for Q2 FY2026
Revenue -36.5% · Operating margin +1.7 pts · Operating income $4.1M narrower — against Q2 FY2025
Read the filingWrite down why you are following Cardlytics, Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
Primary sources and further research
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from CDLX's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Mar 4, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 8 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 2.0 | 5/8 | 10-K, filed Mar 4, 2026 |
| FY2024 | 2.0 | 2/7 | 10-K, filed Mar 12, 2025 |
| FY2023 | 3.3 | 5/7 | 10-K, filed Mar 14, 2024 |
| FY2022 | 3.3 | 2/8 | 10-K, filed Mar 1, 2023 |
| FY2021 | 4.7 | 2/8 | 10-K, filed Mar 1, 2022 |
| FY2020 | 4.7 | 2/8 | 10-K, filed Mar 1, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
-17.09
In the distress zone
For this model, above 2.6 is safe and below 1.1 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +28.5 pts
-76.5% to -48.0%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +25.3 pts
-74.1% to -48.7%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: turned positive
-$10.4M to $8.8MCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: $1.79 narrower
-$3.69 to -$1.90Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Changed: -69.3%
$1.6M to $480.0KCritical
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Deteriorated: -16.9%
$255.6M to $212.3MSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: -25.7%
$65.6M to $48.7MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: +6.4%
51.3M to 54.5MSignificant
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 5, 2026 — read it.
Improved: $4.1M narrower
-$9.6M to -$5.4MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: $5.6M wider
-$9.3M to -$14.9MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −24.3 pts
-16.0% to -40.3%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: $2.55 wider
-$0.18 to -$2.73Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -40.0%
$46.7M to $28.0MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -89.4%
51.3M to 5.5MCritical
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Deteriorated: -36.5%
$58.0M to $36.9MSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +1.7 pts
-16.5% to -14.8%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: -13.9%
$214.3M to $184.4MNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 5, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: $10.4M wider
-$4.5M to -$14.9MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +9.4 pts
-24.1% to -14.8%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −27.3 pts
-13.1% to -40.3%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: $2.65 wider
-$0.08 to -$2.73Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: -90.0%
54.5M to 5.5MCritical
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Improved: $2.8M narrower
-$8.3M to -$5.4MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -21.4%
$35.7M to $28.0MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +7.5%
$34.3M to $36.9MNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: -9.7%
$204.2M to $184.4MNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
1 other measure barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 3% and 8%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 9 analysts covering this company, as of . Their views, not this site's.
Of 9 analysts publishing on this company, 5 say hold, 2 say sell and 2 say strong sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 1.1% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Trailing P/E is not meaningful because the latest trailing earnings are zero or negative. The price-to-book and price-to-sales figures below still provide reference points.
This company has not reported enough of the required figures to calculate this score.
Sold on the open market — 10,351 shares at $2.71 ($28.1K)
Holds 146,288 shares after this filing.
Sold on the open market — 7,382 shares at $2.53 ($18.7K)
Holds 138,906 shares after this filing.
Exercised stock options — 12,500 shares
Holds 126,350 shares after this filing.
Exercised stock options — 12,500 shares
Holds 138,850 shares after this filing.
Sold on the open market — 6,785 shares at $3.97 ($26.9K)
Holds 132,065 shares after this filing.
Sold on the open market — 6,676 shares at $4.03 ($26.9K)
Holds 125,389 shares after this filing.
Exercised stock options — 157 shares
Holds 16,942 shares after this filing.
Exercised stock options — 1,500 shares
Holds 18,442 shares after this filing.
Exercised stock options — 312 shares
Holds 18,754 shares after this filing.
Exercised stock options — 2,750 shares
Holds 21,504 shares after this filing.
Sold on the open market — 2,151 shares at $4.39 ($9.5K)
Holds 19,353 shares after this filing.
Exercised stock options — 12,500 shares
Holds 111,238 shares after this filing.
Exercised stock options — 18,750 shares
Holds 129,988 shares after this filing.
Sold on the open market — 6,498 shares at $4.39 ($28.6K)
Holds 123,490 shares after this filing.
Sold on the open market — 9,640 shares at $4.39 ($42.4K)
Holds 113,850 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 7,382 shares ($18.7K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 10,351 shares ($28.1K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 6,676 shares ($26.9K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 6,785 shares ($26.9K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 9,640 shares ($42.4K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 6,498 shares ($28.6K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results
Received a delisting or listing-standard notice · Changed the rights attached to its shares
Read the filingHeld a shareholder vote
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q1 FY2026
Revenue -39.2% · Operating margin −4.4 pts · Profit $8.8M narrower — against Q1 FY2025
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingCompleted an acquisition or disposal
Read the filingAnnual report for FY2025
Revenue -16.9% · Operating margin +28.5 pts · Operating income $93.7M narrower — against FY2024
Read the filingPublished results
Read the filingSigned a material agreement
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q3 FY2025
Revenue -23.2% · Operating margin +96.5 pts · Operating income $79.7M narrower — against Q3 FY2024
Read the filingPublished results
Read the filingAnnounced restructuring or exit costs · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2025
Revenue -9.3% · Operating margin +8.2 pts · Profit $5.0M wider — against Q2 FY2024
Read the filingPublished results
Read the filing